The aim of the current study was to investigate the effects of
FL118, a novel
camptothecin analogue, on migration and invasion of human
breast cancer cells and the underlying mechanisms of those effects. A 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium
bromide (MTT) assay and a plate clone formation assay were used to examine inhibition of the proliferation of MDA-MB-231 cells by
FL118. Cell cycle distribution was detected using flow cytometry. A wound healing assay and a transwell assay were performed to detect the effects of
FL118 on migration and invasion of MDA-MB-231 cells, respectively. qRT-PCR, Western blotting, and immunocytochemistry were used to study the effects of
FL118 on expression of epithelial-mesenchymal transition (EMT)-related molecules and Wnt/ β-
catenin signaling components in MDA-MB-231 cells. The current results indicated that
FL118 inhibited the proliferation, migration and invasion of MDA-MB-231 cells in a dose- and time-dependent manner.
FL118 caused MDA-MB-231 cells to accumulate in the S phase.
FL118 significantly suppressed the expression of
vimentin while enhancing the expression of
E-cadherin. Moreover, decreased expression of β-
catenin and its targets
survivin and
cyclin Dl was detected in the nucleus of MDA-MB-231 cells. Taken together, the current results suggest that
FL118 inhibited Wnt/β-
catenin signaling, leading to suppressed EMT and decreased migration and invasion of
breast cancer cells.